Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Neurovascular Embolization Devices Market Report Overview
The neurovascular embolization devices market size was $1.33 billion in 2023. The market will grow at a CAGR of more than 2% from 2023 to 2033. Neurovascular embolization devices are used to treat brain aneurysms and arteriovenous malformations (AVM), or any other abnormalities in blood vessels in the brain. These devices occlude or prevent blood flow to unwanted vessel malformations.
Neurovascular Embolization Devices Market Outlook, 2023-2033 ($ Billion)
Buy Full Report for More Insights into the Neurovascular Embolization Devices Market Forecast
Download A Free Report Sample
The neurovascular embolization devices market research report is built to visualize quantitative market trends within the neurology devices therapeutic area. The model discusses in detail the impact of COVID-19 on the neurovascular embolization devices market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2023) | $1.33 billion |
CAGR (2023-2033) | >2% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2023 |
Key Segments | · Aneurysm Clips
· Embolization Coils · Flow Diversion Stents · Intrasaccular Flow Disruptors · Liquid Embolic Systems |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Leading Companies | · Medtronic Plc
· Stryker Corp · Penumbra Inc · MicroVention Inc · Cerenovus |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Neurovascular Embolization Devices Market Dynamics
The neurovascular embolization market will continue to grow driven by advancements in technology and an increase in disease prevalence. Emerging markets such as China, Brazil, Mexico, Poland, Japan, and South Korea will experience faster growth than developed countries. Since there is an established public healthcare system in place, growth will occur once devices and procedures are introduced, more facilities are opened and more specialists are trained. This class of device has the potential for significant and rapid growth, which is currently held back by limited clinical trials, physician hesitation to employ the device due to the required learning curve, and the high cost of the device. As more clinical evidence is gathered on the effectiveness of these devices, Global Data expects this market segment growth to gain momentum over the forecast years.
Neurovascular Embolization Devices Market Segments
The neurovascular embolization devices market can be segmented into Aneurysm Clips, Embolization Coils, Flow Diversion Stents, Intrasaccular Flow Disruptors, and Liquid Embolic Systems. Embolization Coils were the most preferred method of treatment for brain aneurysms in 2023, followed by aneurysm clips and flow diversion stents. They are thin wires that coil and fill up the pocket when deposited into the aneurysm, thus blocking blood from flowing in.
Neurovascular Embolization Devices Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights into the Neurovascular Embolization Devices Market Segments
Neurovascular Embolization Devices Market Segmentation by Regions
The key regions in the neurovascular embolization devices market are North America, Europe, Asia-Pacific, South Central America, and the Middle East and Africa. North America dominated the market in 2023 due to the growing number of facilities, specialists, and increases in cerebrovascular disease. The highest growth is observed in embolization coils in NA. However, the recent approval of WEB Aneurysm Embolization Devices in the US and Canada is expected to negatively impact the embolization coil market. This impact will remain limited due to required physician training and the high price of the WEB device.
Neurovascular Embolization Devices Market Analysis by Regions, 2023 (%)
Buy the Full Report to Know More about the Regions in the Neurovascular Embolization Devices Market
Neurovascular Embolization Devices Market - Competitive Landscape
The leading companies in the neurovascular embolization devices market are Medtronic Plc, Stryker Corp, MicroVention Inc, Cerenovus, Integra LifeSciences Corp, Penumbra Inc, Balt SAS, B. Braun Melsungen AG, and Phenox GmbH among others. Medtronic Plc held the largest neurovascular embolization devices market share in 2023.
Neurovascular Embolization Devices Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More about the Companies in the Neurovascular Embolization Devices Market
Segments Covered in the Report
Neurovascular Embolization Devices Segments Outlook (Value, $ Billion, 2015-2033)
- Aneurysm Clips
- Embolization Coils
- Flow Diversion Stents
- Intrasaccular Flow Disruptors
- Liquid Embolic Systems
Neurovascular Embolization Devices Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions
Key Inclusions of the market model are:
Currently marketed Neurovascular Embolization Devices and evolving competitive landscape –
– Insightful review of the key industry trends.
– Annualized total Neurovascular Embolization Devices market revenue by segment and market outlooks from 2015-2033.
– Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
– SWOT analysis for the Neurovascular Embolization Devices market.
– Competitive dynamics insights and trends provided for the Neurovascular Embolization Devices market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the market access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country-specific overview of the healthcare system.
– Country-specific reimbursement policies.
– Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered – Medtronic Plc, Stryker Corp, MicroVention Inc, Cerenovus, Integra LifeSciences Corp, Penumbra Inc, Balt SAS, B. Braun Melsungen AG, Phenox GmbH, and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have a deep understanding of the Neurovascular Embolization Devices marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the Neurovascular Embolization Devices market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Neurovascular Embolization Devices market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Embolization Devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Neurovascular Embolization Devices market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Stryker Corp
MicroVention Inc
Cerenovus
Integra LifeSciences Corp
Penumbra Inc
Balt SAS
B. Braun Melsungen AG
Phenox GmbH
Others
Frequently asked questions
-
What was the Neurovascular Embolization Devices market size in 2023?
The Neurovascular Embolization Devices market size was $1.33 billion in 2023.
-
Which region held the largest share of the Neurovascular Embolization Devices market?
North America held the largest Neurovascular Embolization Devices market share in 2023.
-
Which segment held the largest share of the Neurovascular Embolization Devices market?
Embolization Coils led the Neurovascular Embolization Devices market in 2023.
-
Which are the major players operating in the Neurovascular Embolization Devices market?
The leading companies in the Neurovascular Embolization Devices market are Medtronic Plc, Stryker Corp, MicroVention Inc, Cerenovus, Integra LifeSciences Corp, Penumbra Inc, Balt SAS, B. Braun Melsungen AG, and Phenox GmbH.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.